Cargando…
Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study
OBJECTIVES: To study the percentage seropositivity for SARS-CoV-2 to understand the pandemic status and predict the future situations in Ahmedabad. STUDY DESIGN: Cross-sectional study. SETTINGS: Field area of Ahmedabad Municipal Corporation. PARTICIPANTS: More than 30 000 individuals irrespective of...
Autores principales: | Prakash, Om, Solanki, Bhavin, Sheth, Jay K, Joshi, Bhavin, Kadam, Mina, Vyas, Sheetal, Shukla, Aparajita, Tiwari, Hemant, Rathod, Sanjay, Rajput, Anil, Trivedi, Toral, Ramanuj, Vaibhav, Solanki, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786546/ https://www.ncbi.nlm.nih.gov/pubmed/33402413 http://dx.doi.org/10.1136/bmjopen-2020-044101 |
Ejemplares similares
-
Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city
por: Prakash, Om, et al.
Publicado: (2021) -
COVID-Kavach-Based Seropositivity in the General Population of Ahmedabad: Just Before the Start of the Vaccination for the Elderly in India
por: Prakash, Om, et al.
Publicado: (2022) -
SARS-CoV2 IgG antibody: Seroprevalence among health care workers
por: Prakash, Om, et al.
Publicado: (2021) -
Seroprevalence of Immunoglobulin-G Antibody Among Confirm Cases of COVID-19
por: Prakash, Om, et al.
Publicado: (2021) -
Screening for gestational diabetes, Ahmedabad, India
por: Nayak, Himanshu, et al.
Publicado: (2022)